Glutathione-dependent bioactivation of haloalkanes and haloalkenes

Drug Metabolism Reviews

Volumn 36, Issue 3-4, 2004, Pages 583-594

  Anders, M W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Betalyase; Glutathione; Glutathione transferase; Haloalkanes; Haloalkenes

Indexed keywords

1,2 DIBROMOETHANE; 1,2 DICHLOROETHANE; ALKANE DERIVATIVE; CHLOROTRIFLUOROETHYLENE; CYSTEINE CONJUGATE BETA LYASE; CYTOCHROME P450; DICHLOROMETHANE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE TRANSFERASE; HALOGENATED HYDROCARBON; HALOOLEFIN; HEXACHLOROBUTADIENE; KETENE DERIVATIVE; SULFONIUM DERIVATIVE; TETRAFLUOROETHYLENE; THIOL DERIVATIVE; TRICHLOROETHYLENE; UNCLASSIFIED DRUG;

ACYLATION; CATALYSIS; CONJUGATION; ENZYME MECHANISM; GLUTATHIONE METABOLISM; HUMAN; NONHUMAN; REVIEW; TOXICITY; XENOBIOTIC METABOLISM;

ALKANES; ALKENES; ANIMALS; BIOTRANSFORMATION; GLUTATHIONE; HUMANS;

EID: 7544236966     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-200033451     Document Type: Review

References (61)

1. 4. J. Biol. Chem. 270:180-188.
2. Ahmed, A. E., Anders, M. W. (1978). Metabolism of dihalomethanes to formaldehyde and inorganic halide. II. Studies on the mechanism of the reaction. Biochem. Pharmacol. 27:2021-2025.
3. Anders, M. W., Dekant, W. (1998). Glutathione-dependent bioactivation of haloalkenes. Annu. Rev. Pharmacol. Toxicol. 38:501-537.
4. Casanova, M., Bell, D. A., Heck, H. d. A. (1997). Dichloromethane metabolism to formaldehyde and reaction of formaldehyde with nucleic acids in hepatocytes of rodents and humans with and without glutathione S-transferase T1 and M1 genes. Fundam. Appl. Toxicol. 37:168-180.
5. Chen, Q., Jones, T. W., Brown, P. C., Stevens, J. L. (1990). The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells. Covalent binding leads to thiol depletion and lipid peroxidation. J. Biol. Chem. 265:21603-21611.
6. Cmarik, J. L., Humphreys, W. G., Bruner, K. L., Lloyd, R. S., Tibbetts, C., Guengerich, F. P. (1992). Mutation spectrum and sequence alkylation selectivity resulting from modification of bacteriophage M13mp18 DNA with S-(2-chloroethyl)glutathione. J. Biol. Chem. 267:6672-6679.
7. Commandeur, J. N. M., Brakenhoff, J. P. G., De Kanter, F. J. J., Vermeulen, N. P. E. (1988). Nephrotoxicity of mercapturic acids of three structurally related 2, 2-difluoroethylenes in the rat. Biochem. Pharmacol. 37:4495-4504.
8. Commandeur, J. N. M., King, L. J., Koymans, L., Vermeulen, N. P. E. (1996). Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate β-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates. Chem. Res. Toxicol. 9:1092-1102.
9. Cooper, A., Bruschi, S., Anders, M. (2002). Toxic, halogenated cysteine S-conjugates and targeting of mitochondrial enzymes of energy metabolism. Biochem. Pharmacol. 64:553-564.
10. Cummings, B. S., Parker, J. C., Lash, L. H. (2000). Role of cytochrome P450 and glutathione S-transferase alpha in the metabolism and cytotoxicity of trichloroethylene in rat kidney. Biochem. Pharmacol. 59:531-543.
11. Davis, M. E. (1988). Effects of AT-125 on the nephrotoxicity of hexachloro-1, 3-butadiene in rats. Toxicol. Appl. Pharmacol. 95:44-52.
12. Dekant, W., Lash, L. H., Anders, M. W. (1987). Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L- cysteine. Proc. Natl. Acad. Sci. U. S. A. 84:7443-7447.
13. Dekant, W., Berthold, K., Vamvakas, S., Henschler, D., Anders, M. W. (1988). Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L- cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate β-lyase. Chem. Res. Toxicol. 1:175-178.
14. Dekant, W., Vamvakas, S., Anders, M. W. (1989). Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate β-lyase. Drug Metab. Rev. 20:43-83.
15. Dekant, W., Urban, G., Görsmann, C., Anders, M. W. (1991). Thioketene formation from α-haloalkenyl 2-nitrophenyl disulfides: models for biological reactive intermediates of cytotoxic S-conjugates. J. Am. Chem. Soc. 113:5120-5122.
16. Dekant, W., Vamvakas, S., Anders, M. W. (1994). Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate β-lyase pathway. Adv. Pharmacol. 27:115-162.
17. Dohn, D. R., Casida, J. E. (1987). Thiiranium ion intermediates in the formation and reactions of S-(2-haloethyl)-L-cysteines. Bioorg. Chem. 15:115-124.
18. Elfarra, A. A., Baggs, R. B., Anders, M. W. (1985). Structure- nephrotoxicity relationships of S-(2-chloroethyl)-DL-cysteine and analogs: role for an episulfonium ion. J. Pharmacol. Exp. Ther. 233:512-516.
19. Elfarra, A. A., Jakobson, I., Anders, M. W. (1986). Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem. Pharmacol. 35:283-288.
20. Finkelstein, M. B., Baggs, R. B., Anders, M. W. (1992). Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene. J. Pharmacol. Exp. Ther. 261:1248-1252.
21. Finkelstein, M. B., Vamvakas, S., Bittner, D., Anders, M. W. (1994). Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds. Chem. Res. Toxicol. 7:157-163.
22. Finkelstein, M. B., Dekant, W., Kende, A. S., Anders, M. W. (1995). α-Thiolactones as novel intermediates in the cysteine conjugate β-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates. J. Am. Chem. Soc. 117:9590-9591.
23. Finkelstein, M. B., Dekant, W., Anders, M. W. (1996). Cysteine conjugate β-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes. Chem. Res. Toxicol. 9:227-231.
24. Guengerich, F. P. (2003). Activation of dihaloalkanes by thiol-dependent mechanisms. J. Biochem. Mol. Biol. 36:20-27.
25. 13C-labeling patterns with 2-bromoacetaldehyde. Chem. Res. Toxicol. 7:205-208.
26. Hargus, S. J., Anders, M. W. (1991). Immunochemical detection of covalently modified kidney proteins in S-(1,1,2,2-tetrafluoroethyl)-L-cysteine- treated rats. Biochem. Pharmacol. 42:R17-R20.
27. 19F NMR: chlorotrifluoroethene and tetrafluoroethene. Chem. Res. Toxicol. 5:34-41.
28. 13C nuclear magnetic resonance spectroscopic studies. Chem. Res. Toxicol. 7:291-296.
29. Hayden, P. J., Welsh, C. J., Yang, Y., Schaefer, W. H., Ward, A. J. I., Stevens, J. L. (1992). Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolites. Chem. Res. Toxicol. 5:231-237.
30. 7-guanyl adducts derived from 1,2-dibromo-3-chloropropane. Chem. Res. Toxicol. 4:445-453.
31. Inskeep, P. B., Guengerich, F. P. (1984). Glutathione-mediated binding of dibromoalkanes to DNA: specificity of rat glutathione S-transferases and dibromoalkane structure. Carcinogenesis 5:805-808.
32. Jolivette, L. J., Anders, M. W. (2002). Structure-activity relationship for the biotransformation of haloalkenes by rat liver microsomal glutathione transferase 1. Chem. Res. Toxicol. 15:1036-1041.
33. Jolivette, L. J., Anders, M. W. (2003). Computational and experimental studies on the distribution of addition and substitution products of the microsomal glutathione transferase 1-catalyzed conjugation of glutathione with fluoroalkenes. Chem. Res. Toxicol. 16:137-144.
34. Kharasch, E. D., Thorning, D., Garton, K., Hankins, D. C., Kilty, G. C. (1997). Role of renal cysteine conjugate β-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 86:160-171.
35. Kharasch, E. D., Hoffman, G. M., Thorning, D., Hankins, D. C., Kilty, C. G. (1998). Role of the renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology 88:1624-1633.
36. 1-adenyl)ethyl]glutathione as an adduct formed in RNA and DNA from 1, 2-dibromoethane. Chem. Res. Toxicol. 3:587-594.
37. Kubic, V. L., Anders, M. W. (1978). Metabolism of dihalomethanes to carbon monoxide-III. Studies on the mechanisms of the reaction. Biochem. Pharmacol. 27:2349-2355.
38. Lantum, H. B. M., Iyer, R. A., Anders, M. W. (2004). Acivicin-induced alterations in renal and hepatic glutathione concentrations and in β-glutamyltransferase activities. Biochem. Pharmacol. 67:1421-1426.
39. Lash, L. H., Anders, M. W. (1986). Cytotoxicity of 5-(1,2-dichlorovinyl) glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J. Biol. Chem. 261:13076-13081.
40. Lash, L. H., Anders, M. W. (1987). Mechanism of S-(1,2-dichlorovinyl)-L- cysteine- and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity. Mol. Pharmacol. 32:549-556.
41. Lash, L. H., Anders, M. W. (1989). Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells. J. Pharmacol. Exp. Ther. 248:531-537.
42. Livesey, J. C., Anders, M. W., Langvardt, P. W., Putzig, C. L., Reitz, R. H. (1982). Stereochemistry of the glutathione-dependent biotransformation of vicinal-dihaloalkanes to alkenes. Drug Metab. Dispos. 10:201-204.
43. Marsch, G. A., Botta, S., Martin, M. V., McCormick, W. A., Guengerich, F. P. (2004). Formation and mass spectrometric analysis of DNA and nucleoside adducts by S-(1-acetoxymethyl)glutathione and by glutathione S-transferase-mediated activation of dihalomethanes. Chem. Res. Toxicol. 17:45-54.
44. Martin, J. L., Laster, M. J., Kandel, L., Kerschmann, R. L., Reed, G. F., Eger, E. I. II. (1996). Metabolism of compound A by renal cysteine-S-conjugate β-lyase is not the mechanism of compound A-induced renal injury in the rat. Anesth. Analg. 82:770-774.
45. Martin, J. L., Kandel, L., Laster, M. J., Kerschmann, R. L., Eger, E. I. II. (1997). Studies on the mechanism of nephrotoxicity of compound A in rats. J. Anesthesiol. 11:32-37.
46. 7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA. Proc. Natl. Acad. Sci. U. S. A. 80:5266-5270.
47. 7-guanyl) ethyl]glutathione in DNA. J. Am. Chem. Soc. 110:3284-3291.
48. Rannug, U., Beije, B. (1979). The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium. II. Activation by the isolated perfused rat liver. Chem. Biol. Interact. 24:265-285.
49. Reitz, R. H., Mendrala, A. L., Guengerich, F. P. (1989). In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97:230-246.
50. Schaeffer, V. H., Stevens, J. L. (1987a). Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles. Mol. Pharmacol. 32:293-298.
51. Schaeffer, V. H., Stevens, J. L. (1987b). The transport of S-cysteine conjugates in LLC-PK1 cells and its role in toxicity. Mol. Pharmacol. 31:506-512.
52. Shim, J.-Y., Richard, A. M. (1997). Theoretical evaluation of two plausible routes for bioactivation of S-(1,1-difluoro-2,2-dihaloethyl)-L- cysteine conjugates: thiirane vs. thionoacyl fluoride pathway. Chem. Res. Toxicol. 10:103-110.
53. Stevens, J. L., Robbins, J. D., Byrd, R. A. (1986a). A purified cysteine conjugate β-lyase from rat kidney cytosol. Requirement for an α-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K. J. Biol. Chem. 261:15529-15537.
54. Stevens, J., Hayden, P., Taylor, G. (1986b). The role of glutathione conjugate metabolism and cysteine conjugate β-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells. J. Biol. Chem. 261:3325-3332.
55. Thier, R., Taylor, J. B., Pemble, S. E., Humphreys, W. G., Persmark, M., Ketterer, B., Guengerich, F. P. (1993). Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc. Natl. Acad. Sci. U. S. A. 90:8576-8580.
56. van Bladeren, P. J., van der Gen, A., Breimer, D. D., Mohn, G. R. (1979). Stereoselective activation of vicinal dihalogen compounds to mutagens by glutathione conjugation. Biochem. Pharmacol. 28:2521-2524.
57. van Bladeren, P. J., Breimer, D. D., van Huijgevoort, J. A. T. C. M., Vermeulen, N. P. E., van der Gen, A. (1981). The metabolic formation of N-acetyl-S-2-hydroxyethyl-L-cysteine from tetradeutero-1,2-dibromoethane. Relative importance of oxidation and glutathione conjugation in vivo. Biochem. Pharmacol. 30:2499-2502.
58. Völkel, W., Dekant, W. (1998). Chlorothioketene, the ultimate reactive intermediate formed by cysteine conjugate β-lyase-mediated cleavage of the trichloroethene metabolite S-(1,2-Dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution. Chem. Res. Toxicol. 11:1082-1088.
59. Webb, W. W., Elfarra, A. A., Webster, K. D., Thom, R. E., Anders, M. W. (1987). Role for an episulfonium ion in S-(2-chloroethyl)-DL-cysteine-induced cytotoxicity and its reaction with glutathione. Biochemistry 26:3017-3023.
60. Wheeler, J. B., Stourman, N. V., Thier, R., Dommermuth, A., Vuilleumier, S., Rose, J. A., Armstrong, R. N., Guengerich, F. P. (2001). Conjugation of haloalkanes by bacterial and mammalian glutathione transferases: mono- and dihalomethanes. Chem. Res. Toxicol. 14:1118-1127.
61. Zhang, T.-L., Wang, L., Hashmi, M., Anders, M. W., Thorpe, C., Ridge, D. P. (1995). Fourier-transform ion cyclotron resonance mass spectrometric evidence for the formation of α-chloroethenethiolates and thioketenes from chloroalkene-derived, cytotoxic 4-thiaalkanoates. Chem. Res. Toxicol. 8:907-910.